HTL Biotechnology inaugurated its new HTL8 production unit at its Javené site on Thursday, November 12, 2026. The €15 million facility is dedicated to manufacturing pharmaceutical-grade polynucleotides.
Investment and Expansion
HTL Biotechnology inaugurated its new HTL8 production unit on Thursday, November 12, 2026, at its Javené site in Ille-et-Vilaine. The €15 million investment forms part of the group's broader international development strategy and its 2022-2026 investment plan totaling €100 million.
CEO François Fournier said the new unit is fully in line with the company's investment plan. Fournier stated that the company is committed to monitoring markets and anticipating developments by placing customer expectations at the heart of its strategy.
Applications and Materials
The new unit focuses on the purification of pharmaceutical-grade polynucleotides, which are biopolymers formed by chains of nucleotides. These materials attract interest for regenerative properties such as promoting tissue repair, hydration, and improved skin quality.
HTL Biotechnology manufactures its polynucleotides using DNA extracted from wild Alaskan salmon milt. The facility is designed to meet industrial and pharmaceutical standards to support applications in regenerative medicine, ophthalmology, and dermatology.
Key facts and where they come from
- HTL Biotechnology inaugurated its new production unit, HTL8, on Thursday, November 12, 2026, at its Javené site.
Thursday, November 12, HTL Biotechnology, a world leader in the development and production of pharmaceutical-grade biopolymers, inaugurated its new production unit, HTL8
- The HTL8 project represents a €15 million investment by the company.
This €15 million investment marks a structuring step in the group's international development strategy and in the diversification of its biopolymer portfolio.
- The company manufactures polynucleotides from DNA extracted from wild Alaskan salmon milt.
HTL Biotechnology manufactures its polynucleotides from DNA extracted from wild Alaskan salmon milt, a co-product of the salmon industry
The catch
- The announcement does not specify the exact timeline for when commercial production at HTL8 will begin.
- The specific manufacturing capacity and output volume of the new production unit were not disclosed.
